MUMBAI, India, March 14 -- Intellectual Property India has published a patent application (202617016821 A) filed by Omeros Corporation, Seattle, on Feb. 16, for 'pde 7 modulator compounds.'
Inventor(s) include Cutshall, Neil S; Hadd, Mark A; Keshipeddy, Santosh Kumar; Lemus, Robert H; and Metz, Markus.
The application for the patent was published on March 13, under issue no. 11/2026.
According to the abstract released by the Intellectual Property India: "Compounds having activity as modulators of phosphodiesterase 7 (PDE 7) are provided. The compounds have the following Structures (I) or (II): (I) (II) as a stereoisomer, enantiomer, or tautomer thereof or a mixture thereof; or a pharmaceutically acceptable salt, solvate or prodrug thereof, wherein each of R1, R2, R3, R4a, R4b, ring A, ring B, ring A' and ring B' (i.e.,, B, A', and B' as shown in Structure (I) and (II), respectively) are as defined herein. Methods associated with preparation and use of such compounds, pharmaceutical compositions comprising such compounds and methods to modulate the activity of phosphodiesterase 7 (PDE 7) are also provided."
The patent application was internationally filed on Aug. 21, 2024, under International application No.PCT/US2024/043176.
Disclaimer: Curated by HT Syndication.
